Ossur operates in the Surgical appliances and supplies sector. Ossur hf. is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company is divided into three market segments: Bracing and Supports, which offers products for therapeutic and preventive purposes; Prosthetics, which offers products for amputees, which include sockets, sleeves, prosthetic knees and feet, as well as supporting components, and Compression Therapy, which offers treatment for venous ulcers and edema. The Company's main markets are North America, Europe and Asia. It has subsidiaries in Iceland, the United Kingdom, the Netherlands, Sweden, France, China, Australia, the United States and Canada. The Company's major shareholders are William Demant Invest A/S with 37.3% of shares, Eyrir Invest ehf with 13.8% of shares, ATP with 6.2% of shares and Fidelity Investments with 6% of shares. In our complete report available for purchase the company is compared to: Sartorius Stedim Biotech Sa, Arkimedica SPA and Ambu A/S.